用友網絡(600588.SH):控股子公司境內未上市股份申請全流通實施完成
格隆匯6月19日丨用友網絡(600588.SH)公佈,截至2025年6月19日,公司控股子公司暢捷通合計53,401,211股境內未上市股份(其中包括公司直接持有的201,479,637股中的28,135,271股,以及公司全資子公司用友優普信息技術有限公司和控股子公司北京用友幸福投資管理有限公司分別所持有的全部13,972,978股和1,006,176股)轉換爲H股的股份轉換程序已全部實施完畢。暢捷通已根據有關規定辦理了上述股份的登記存管及上市程序,上述股份將於2025年6月20日上午九點整開始在香港聯合交易所有限公司主板上市交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.